Cargando…

Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate–Severe Symptoms

INTRODUCTION: The assessment of future risk has become an important feature in the management of patients with asthma. However, the contribution of patient-specific characteristics and treatment choices to the risk of exacerbation is poorly understood. Here we evaluated the effect of interindividual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Dave, Oosterholt, Sean, Pavord, Ian, Garcia, Gabriel, Abhijith PG, Della Pasqua, Oscar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499702/ https://www.ncbi.nlm.nih.gov/pubmed/37589831 http://dx.doi.org/10.1007/s12325-023-02590-2

Ejemplares similares

Characterisation of individual ferritin response in patients receiving chelation therapy
por: Borella, Elisa, et al.
Publicado: (2022)

The burden of exacerbations in mild asthma: a systematic review
por: FitzGerald, J. Mark, et al.
Publicado: (2020)

Achieving Symptom Control in Patients with Moderate Asthma
por: Weir, Nargues A., et al.
Publicado: (2011)

Symptoms and exacerbations in asthma: an apparent paradox?
por: Morjaria, Jaymin B., et al.
Publicado: (2019)

Predictive factors for moderate or severe exacerbations in asthma patients receiving outpatient care
por: Gutiérrez, Francisco Javier Álvarez, et al.
Publicado: (2017)

Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma
por: Khan, Asif H, et al.
Publicado: (2022)

Model‐based meta‐analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms
por: D'Agate, Salvatore, et al.
Publicado: (2020)

Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
por: Castro, Mario, et al.
Publicado: (2020)

Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST
por: Maspero, Jorge F., et al.
Publicado: (2021)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Monitoring asthma in childhood: symptoms, exacerbations and quality of life
por: Brand, Paul L.P., et al.
Publicado: (2015)

Impact of asthma severity as risk factor to future exacerbations in patients admitted for asthma exacerbation
por: Nakwan, Narongwit
Publicado: (2021)

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
por: de Boer, Geertje, et al.
Publicado: (2021)

BiPAP for treating moderate and severe asthma exacerbations in a PED
por: Williams, A, et al.
Publicado: (2013)

Asthma control and severe exacerbations in patients with moderate or severe asthma in Jilin Province, China: a multicenter cross-sectional survey
por: Yan, Bing-di, et al.
Publicado: (2016)

Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma
por: YILMAZ, İnsu, et al.
Publicado: (2021)

Model‐based meta‐analysis of the time to first acute urinary retention or benign prostatic hyperplasia‐related surgery in patients with moderate or severe symptoms
por: D'Agate, Salvatore, et al.
Publicado: (2021)

Leukocytes in Critical Patients With Asthma Exacerbation
por: Rabah, Hussein, et al.
Publicado: (2021)

The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients
por: Kritikos, Vicky, et al.
Publicado: (2020)

Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma
por: Papi, Alberto, et al.
Publicado: (2022)

Understanding the journeys of patients with an asthma exacerbation requiring urgent therapy at a primary care clinic
por: Quek, Jing Sheng, et al.
Publicado: (2022)

Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome
por: Glaze, Daniel G., et al.
Publicado: (2019)

Severe and Moderate Asthma Exacerbations in Asthmatic Children and Exposure to Ambient Air Pollutants
por: Tétreault, Louis-Francois, et al.
Publicado: (2016)

Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma
por: Corren, Jonathan, et al.
Publicado: (2021)

Asthma in pregnancy: An update
por: Couillard, Simon, et al.
Publicado: (2020)

Patient Preferences for Attributes of Biologic Treatments in Moderate to Severe Asthma: A Discrete Choice Experiment Study
por: Yang, Min, et al.
Publicado: (2022)

Evaluating minimal important differences and responder definitions for the asthma symptom diary in patients with moderate to severe asthma
por: Globe, Gary, et al.
Publicado: (2019)

5613464 INTEGRATION OF PHARMACOKINETIC AND PHARMACODYNAMIC MODELS TO MULTI-CRITERIA DECISION ANALYSIS (MCDA) FOR PROSPECTIVE ASSESSMENT OF THE RISK-BENEFIT RATIO OF ORAL IRON CHELATORS IN PAEDIATRIC PATIENTS WITH TRANSFUSION-DEPENDENT HAEMOGLOBINOPATHIES
por: Della Pasqua, O.D.P., et al.
Publicado: (2023)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
por: Price, David B., et al.
Publicado: (2019)

Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
por: Singh, Dave, et al.
Publicado: (2019)

Lymphocytes apoptosis in patients with acute exacerbation of asthma.
por: Hamzaoui, A, et al.
Publicado: (1999)

Efficacy of ciclesonide in the treatment of patients with asthma exacerbation
por: Zietkowski, Ziemowit, et al.
Publicado: (2019)

Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
por: De Prado Gomez, Lucia, et al.
Publicado: (2023)

Role of Intravenous Magnesium in the Management of Moderate to Severe Exacerbation of Asthma: A Literature Review
por: Bokhari, Syed A, et al.
Publicado: (2022)

Perspective on the Budgetary Impact of FP/FORM pMDI on Treatment and Management of Exacerbation in Moderate-to-Severe Asthma Patients in Singapore
por: Boisseau, Sebastien, et al.
Publicado: (2020)

Patient-Reported Control of Asthma, Nasal Polyposis, and Middle-Ear Symptoms in NSAID-Exacerbated Respiratory Disease
por: Suikkila, Anna, et al.
Publicado: (2021)

Aspirin-Exacerbated Asthma
por: Varghese, Mathew, et al.
Publicado: (2008)

Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression
por: D’Agate, Salvatore, et al.
Publicado: (2020)

Is this an alternative? Time to understand patients’ choices
Publicado: (2019)

The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA
por: Suruki, Robert Y., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mommhtfvc159ipprik254qukc4